STOCK TITAN

Nasdaq warns Iveda Solutions (IVDA) on $1 bid rule with Sept. 2026 deadline

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.

The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.

Positive

  • None.

Negative

  • Nasdaq minimum bid price deficiency increases the risk of eventual delisting if Iveda Solutions, Inc. cannot lift and sustain its share price to at least $1 for ten consecutive business days within the 180-day compliance window ending September 2, 2026.

Insights

Nasdaq bid-price noncompliance creates delisting risk but with a defined cure window.

Iveda Solutions has fallen out of compliance with Nasdaq’s $1 minimum bid price rule after 30 consecutive business days below that threshold. This triggers a formal deficiency period but leaves the current listing intact for now.

The company has until September 2, 2026 to regain compliance by maintaining a closing bid of at least $1 for ten consecutive business days. Failure to do so allows Nasdaq to start delisting proceedings, though Iveda would be able to request a hearing before a Nasdaq Hearings Panel, as described in the notice.

false 0001397183 0001397183 2026-03-06 2026-03-06 0001397183 IVDA:CommonStockParValue0.00001Member 2026-03-06 2026-03-06 0001397183 IVDA:CommonStockPurchaseWarrantsMember 2026-03-06 2026-03-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

March 6, 2026

Date of Report (Date of earliest event reported)

 

IVEDA SOLUTIONS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41345   20-2222203
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

1744 S. Val Vista, Suite 213

Mesa, Arizona

  85204
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (480) 307-8700

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.00001   IVDA   The Nasdaq Stock Market LLC
Common Stock Purchase Warrants   IVDAW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On March 6, 2026, Iveda Solutions, Inc., a Delaware corporation (the “Company”), received a letter (the “Letter”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company’s common stock failed to maintain a minimum bid price of $1 per share, based upon the closing bid price for the last 30 consecutive business days. Accordingly, the Company failed to comply with Rule 5550(a)(2) the Nasdaq Listing Rules (the “Rules”).

 

The Notice has no immediate effect on the listing of the Company’s common stock on Nasdaq. Rule 5810(c)(3)(A) provides the Company a compliance period of 180 calendar days, or until September 2, 2026, in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company’s common stock is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide the Company written confirmation of compliance with the Rules and this matter will be closed.

 

If the Company does not regain compliance within the compliance period, or if the Company fails to satisfy another Nasdaq requirement for continued listing, Nasdaq could provide notice that the Company’s securities will become subject to delisting. In such event, Nasdaq rules would permit the Company to appeal the decision to reject any delisting determination to a Nasdaq Hearings Panel.

 

The Company, by filing this Form 8-K, discloses its receipt of the Letter in accordance with Nasdaq Listing Rule 5810(b).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 6, 2026    
     
  IVEDA SOLUTIONS, INC.
     
  By: /s/ Robert J. Brilon
  Name: Robert J. Brilon
  Title: Chief Financial Officer

 

 

 

FAQ

What Nasdaq issue did Iveda Solutions (IVDA) disclose on March 6, 2026?

Iveda Solutions disclosed receiving a Nasdaq notice that its common stock failed to maintain the required minimum bid price of $1 per share for 30 consecutive business days, placing the company out of compliance with Nasdaq Listing Rule 5550(a)(2) and starting a formal cure period.

Does the Nasdaq deficiency notice immediately affect IVDA’s stock listing?

The Nasdaq notice has no immediate effect on Iveda Solutions’ Nasdaq listing. The company’s common stock continues trading while it works to regain compliance with the $1 minimum bid price requirement during the specified 180-day grace period described in the notice.

How long does Iveda Solutions (IVDA) have to regain Nasdaq bid price compliance?

Iveda Solutions has 180 calendar days, until September 2, 2026, to regain compliance. The company must achieve a closing bid price of at least $1 per share for a minimum of ten consecutive business days within this period for Nasdaq to confirm compliance.

What happens if IVDA’s share price stays below $1 through September 2, 2026?

If Iveda Solutions does not regain compliance by September 2, 2026, or violates other listing standards, Nasdaq may determine that its securities are subject to delisting. In that event, Iveda would be permitted under Nasdaq rules to appeal the delisting decision to a Nasdaq Hearings Panel.

What specific Nasdaq rules are involved in Iveda Solutions’ (IVDA) deficiency notice?

The situation involves Nasdaq Listing Rule 5550(a)(2), which sets the $1 minimum bid price, and Rule 5810(c)(3)(A), which grants a 180-day compliance period. The company reported the notice under Nasdaq Listing Rule 5810(b), which requires public disclosure of such deficiency communications.

Filing Exhibits & Attachments

4 documents
Iveda Solutions

NASDAQ:IVDA

View IVDA Stock Overview

IVDA Rankings

IVDA Latest News

IVDA Latest SEC Filings

IVDA Stock Data

3.29M
11.11M
Security & Protection Services
Services-prepackaged Software
Link
United States
MESA